FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a pharmaceutical composition containing cholest-4-en-3-one oxime and oil specified in sesame oil, olive oil, soya oil, cottonseed oil or mixed medium-chain triglycerides (ESTASAN®, MYGLIOL®) or mixed oils, preferentially sesame oil, olive oil and soya oil, more preferentially sesame oil.
EFFECT: invention ensures chemical stability of the dosage form, higher concentration of the solubilised active ingredients, higher biological availability of the active ingredient.
6 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF AT LEAST ONE DERIVATIVE OF CHOLEST-4-EN-3-ONE OXIME AS ANTIOXIDANT | 2008 |
|
RU2475052C2 |
| NEW COMPOSITION FOR SOFT GELATIN RETINOID-CONTAINING CAPSULES | 2004 |
|
RU2344810C2 |
| NEW COMPOSITION FOR TREATING SIDE EFFECTS OF ANTI-CANCER THERAPY | 2008 |
|
RU2485956C2 |
| APPLICATION OF CHOLEST-4-ENE-3-ONE DERIVATIVES FOR PREPARING CYTOPROTECTIVE DRUG | 2007 |
|
RU2428189C2 |
| FORMULATIONS OF VITAMIN D 14-EPI-ANALOGUES | 2011 |
|
RU2575792C2 |
| EAR HYGIENE DRUG | 2005 |
|
RU2431486C2 |
| NEW FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D | 2011 |
|
RU2575819C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING BICYCLIC COMPOUND, AND METHOD OF BICYCLIC COMPOUND STABILISATION | 2007 |
|
RU2440144C2 |
| COMPOSITION IN SOFT GELATIN CAPSULE | 2007 |
|
RU2420291C2 |
| LIPID COMPOSITIONS OF RACECADOTRIL | 2013 |
|
RU2632441C2 |
